Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Systemic corticosteroids help manage vitiligo by slowing progression and aiding repigmentation.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Low-dose oral minoxidil is an effective and safe treatment for hair loss.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

ZD1839 can cause skin issues like acne and hair changes.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

4-(Ethoxycarbophenyl) retinamide is much less toxic than other retinoids.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

Ritlecitinib is a new treatment for severe hair loss in people 12 and older.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

New and repurposed treatments are improving outcomes in dermatology.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Using minoxidil and anthralin together can improve hair regrowth in severe alopecia areata patients who didn't respond to individual treatments.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.